查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1547080

乳房病變定位市場：2024-2031年全球產業分析、規模、佔有率、成長、趨勢、預測

Breast Lesion Localization Methods Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 154 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球乳房病變定位市場的詳細報告。本報告對驅動因素、趨勢、機會和挑戰等關鍵市場動態進行了全面分析，提供了對市場結構的深入見解。

主要見解

  • 乳房病灶定位市場規模（2024年）：25.2億美元
  • 預估市值（2031年）：68億美元
  • 全球市場成長率（2024-2031年年複合成長率）：5.7%

乳房病變定位市場：調查範圍

乳房病變定位市場包括用於在手術或切片檢查之前精確定位和標記乳房內異常組織的各種技術和設備。這些方法對於精確去除癌症或可疑組織、最大限度地減少對周圍健康組織的損害以及改善患者的治療效果非常重要。該市場服務於醫院、門診手術中心和專科診所等不同領域。乳癌發病率的不斷上升、影像技術的進步以及微創手術在各種醫療保健環境中的廣泛應用推動了這一成長。

推動市場成長的因素：

有幾個關鍵因素推動全球乳房病變定位市場。隨著越來越多的患者需要準確的病變定位，全球乳癌發生率的上升推動市場成長。診斷影像和定位技術的技術進步，例如無線和放射性種子定位方法的開發，提高乳房病變定位的準確性和安全性，進一步刺激市場擴張。此外，早期檢測意識的提高和篩檢計劃可用性的提高推動需求。加強研發活動以及創新設備和技術的引進，為具有各種醫療需求的患者提供更好的解決方案，促進市場成長。

市場限制因素：

儘管成長前景廣闊，但乳房病變定位市場受到先進定位技術的高成本以及與某些方法相關的潛在風險的限制，例如線移動和種子錯位面臨與重大風險相關的挑戰。此外，替代診斷影像解決方案的可用性也可能阻礙市場成長，這種解決方案可能因其非侵入性而受到一些醫療保健提供者的青睞。此外，對在資源匱乏的環境中獲得先進的本地化診斷方法的擔憂對市場擴張構成了挑戰。解決這些問題需要持續投資於研究和開發，以提高乳房病變定位方法的安全性、可負擔性和可近性。

市場機會：

這個市場的一個重要機會是日益採用無線和放射性種子定位技術，以提高患者的舒適度和治療效果。數位乳房斷層合成和磁振造影（MRI）等先進影像技術的發展是為了滿足對更準確、侵入性更小的定位選項日益成長的需求。新興市場醫療保健基礎設施的擴張為市場成長提供了新的管道，使公司能夠覆蓋更多的患者群體並提供尖端的本地化方法。戰略合作夥伴關係、投資醫療保健專業人員培訓計劃以及採用以患者為中心的方法對於利用新的商機和保持市場領先地位非常重要。

報告中回答的主要問題

  • 推動全球乳房病變定位市場成長的關鍵因素是什麼？
  • 哪些類型和技術的乳房病變定位在各種醫療機構中處於領先地位？
  • 技術進步如何影響乳房病變定位市場的競爭格局？
  • 誰是乳房病變定位市場的主要參與者？ 他們採取哪些策略來保持競爭力？
  • 全球乳房病變定位市場有何新趨勢與前景？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 課題
    • 主要趨勢
  • 宏觀經濟因素
    • 世界 GDP 成長前景
    • 全球醫療保健產業概覽
  • 預測因子 - 相關性和影響

第3章 增值見解

  • 產品類型生命週期分析
  • 母市場分析
  • 疾病流行病學
  • 新冠肺炎（COVID-19）影響評估
  • PESTLE分析
  • 波特五力分析
  • 監管與科技環境

第4章 全球乳房病變定位市場展望：實績（2019-2023年）與預測（2024-2031年）

  • 主要亮點
    • 市場規模及年成長率
    • 絕對數量的機會
  • 市場規模分析與預測（十億美元）
    • 過去的市場規模分析，2019-2023年
    • 目前市場規模預測（2023-2031年）
  • 全球乳房病變定位市場展望：技術類型
    • 簡介/主要發現
    • 2019-2023年歷史市場規模（十億美元）分析，依技術類型
    • 2024-2031年當前市場規模（十億美元）預測，依技術類型
  • 市場吸引力分析：技術類型
  • 全球乳房病變定位市場展望：最終用戶
    • 簡介/主要發現
    • 2019-2023年歷史市場規模（十億美元）分析，依最終用戶
    • 對2024-2031年當前市場規模（十億美元）預測，依最終用戶
  • 市場吸引力分析：最終用戶

第5章 全球乳房病變定位市場展望：地區

  • 主要亮點
  • 2019-2023年歷史市場規模（十億美元）分析，依地區
  • 2024-2031年當前市場規模（十億美元）預測，依地區
    • 北美
    • 歐洲
    • 東亞
    • 南亞/大洋洲
    • 拉丁美洲
    • 中東和非洲（MEA）
  • 市場吸引力分析：地區

第6章 北美乳房病變定位市場展望：實績（2019-2023）與預測（2024-2031）

第7章 歐洲乳房病變定位市場展望：實績（2019-2023年）與預測（2024-2031年）

第8章 東亞乳房病變定位市場展望：實績（2019-2023）與預測（2024-2031）

第9章 南亞和大洋洲乳房病變定位市場展望：實績（2019-2023年）和預測（2024-2031年）

第10章 拉丁美洲乳房病變定位市場展望：實績（2019-2023年）與預測（2024-2031年）

第11章 中東與非洲乳房病變定位市場展望：實績（2019-2023）與預測（2024-2031）

第12章 競爭態勢

  • 2024年市佔率分析
  • 市場結構
    • 競爭強度圖：依市場劃分
    • 競爭儀表板
    • 表觀產能
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • Merit Medical Systems
    • BD
    • ARGON MEDICAL
    • Hologic, Inc.
    • Endomagnetics Ltd.
    • MatekMedikal
    • Sirius Medical Systems BV
    • Izi Medical Products, LLC
    • Molli Surgical Inc
    • Elucent Medical
    • Intramedical Imaging
    • Isoaid
    • Vigeosrl
    • Medax Medical Devices
    • MDL SRL
    • BPB Medica
    • Sterylab SRL
    • Tsunami Medical Srl
    • Laurane（R）Medical LLC
    • Biomedical Srl

第13章 附錄

  • 調查方法
  • 調查的先決條件
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP34739

Persistence Market Research has recently published an extensive report on the global Breast Lesion Localization Methods Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Breast Lesion Localization Methods Market Size (2024E): US$2.52 Bn
  • Projected Market Value (2031F): US$6.8 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 5.7%

Breast Lesion Localization Methods Market - Report Scope:

The Breast Lesion Localization Methods Market encompasses a variety of techniques and devices used to accurately locate and mark the position of abnormal tissue in the breast, typically prior to surgery or biopsy. These methods are critical for ensuring precise removal of cancerous or suspicious tissue, minimizing damage to surrounding healthy tissue, and improving patient outcomes. The market serves diverse segments, including hospitals, ambulatory surgical centers, and specialty clinics. Growth is driven by the increasing prevalence of breast cancer, advancements in imaging technologies, and the expanding application of minimally invasive procedures across various healthcare settings.

Market Growth Drivers:

Several key factors are driving the global Breast Lesion Localization Methods Market. The rising incidence of breast cancer globally boosts the market's growth as more patients require accurate lesion localization. Technological advancements in imaging and localization techniques, such as the development of wireless and radioactive seed localization methods, have improved the precision and safety of breast lesion localization, further fueling market expansion. Additionally, the growing awareness of early detection and the increasing availability of screening programs drive demand. Enhanced research and development activities, along with the introduction of innovative devices and techniques, contribute to market growth by offering more tailored solutions for patients with different medical needs.

Market Restraints:

Despite promising growth prospects, the Breast Lesion Localization Methods Market faces challenges related to the high costs of advanced localization techniques and the potential risks associated with certain methods, such as wire migration or seed displacement. Market growth can be hindered by the availability of alternative imaging and diagnostic solutions, which may be preferred by some healthcare providers due to their non-invasive nature. Additionally, concerns about the accessibility of advanced localization methods in low-resource settings pose challenges for market expansion. Addressing these issues requires ongoing investment in research and development to improve the safety, affordability, and accessibility of breast lesion localization methods.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of non-wire and radioactive seed localization methods, which offer improved patient comfort and outcomes. The development of advanced imaging technologies, such as digital breast tomosynthesis and magnetic resonance imaging (MRI), caters to the growing need for more accurate and less invasive localization options. The expansion of healthcare infrastructure in emerging markets provides new channels for market growth, allowing companies to reach a broader patient population and offer access to cutting-edge localization methods. Strategic partnerships, investments in training programs for healthcare professionals, and the introduction of patient-centered approaches are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Breast Lesion Localization Methods Market globally?
  • Which types and techniques of breast lesion localization are leading the adoption in various healthcare settings?
  • How are technological advancements influencing the competitive landscape of the Breast Lesion Localization Methods Market?
  • Who are the key players in the Breast Lesion Localization Methods Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Breast Lesion Localization Methods Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Breast Lesion Localization Methods Market, including Hologic Inc., Becton, Dickinson and Company, and Leica Biosystems, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced localization solutions and explore new imaging techniques. Collaborations with healthcare providers, research institutions, and technology developers facilitate market access and promote new product adoption. Emphasis on patient education, high-quality products, and comprehensive training programs fosters market growth and enhances brand loyalty in the evolving Breast Lesion Localization Methods Market landscape.

Key Companies Profiled:

  • Merit Medical Systems
  • BD
  • ARGON MEDICAL
  • Hologic, Inc.
  • Endomagnetics Ltd.
  • MatekMedikal
  • Sirius Medical Systems B.V.
  • Izi Medical Products, LLC
  • Molli Surgical Inc
  • Elucent Medical
  • Intramedical Imaging
  • Isoaid
  • Vigeosrl
  • Medax Medical Devices
  • MDL SRL
  • BPB Medica
  • Sterylab S.R.L.
  • Tsunami Medical Srl
  • Laurane(R) Medical LLC
  • Biomedical Srl

Breast Lesion Localization Methods Market Industry Segmentation

By Technology Type

  • Wire Localization
  • Radioguided Localization
  • Magnetic Localization
  • Ultrasound-guided Localization
  • Stereotactic Localization

By End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Specialty Clinics

By Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • Asia Pacific and Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Breast Lesion Localization Methods Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, (US$ Bn)
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Growth Outlook
    • 2.3.2. Global Healthcare Industry Overview
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Type Lifecycle Analysis
  • 3.2. Parent Market Analysis
  • 3.3. Disease Epidemiology
  • 3.4. Covid-19 Impact Assessment
  • 3.5. PESTLE Analysis
  • 3.6. Porter Five Force's Analysis
  • 3.7. Regulatory and Technology Landscape

4. Global Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Size and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size Analysis, 2019-2023
    • 4.2.2. Current Market Size Forecast, 2023-2031
  • 4.3. Global Breast Lesion Localization Methods Market Outlook: Technology Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis By Technology Type, 2019-2023
    • 4.3.3. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
      • 4.3.3.1. Wire Localization
      • 4.3.3.2. Radioguided Localization
      • 4.3.3.3. Magnetic Localization
      • 4.3.3.4. Ultrasound-guided Localization
      • 4.3.3.5. Stereotactic Localization
  • 4.4. Market Attractiveness Analysis: Technology Type
  • 4.5. Global Breast Lesion Localization Methods Market Outlook: End-User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
    • 4.5.3. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
      • 4.5.3.1. Hospitals
      • 4.5.3.2. Diagnostic Imaging Centers
      • 4.5.3.3. Specialty Clinics
  • 4.6. Market Attractiveness Analysis: End User

5. Global Breast Lesion Localization Methods Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 5.3. Current Market Size (US$ Bn) Forecast By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa (MEA)
  • 5.4. Market Attractiveness Analysis: Region

6. North America Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 6.2.1. By Country
    • 6.2.2. By Technology Type
    • 6.2.3. By End User
  • 6.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 6.4.1. Wire Localization
    • 6.4.2. Radioguided Localization
    • 6.4.3. Magnetic Localization
    • 6.4.4. Ultrasound-guided Localization
    • 6.4.5. Stereotactic Localization
  • 6.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 6.5.1. Hospitals
    • 6.5.2. Diagnostic Imaging Centers
    • 6.5.3. Specialty Clinics
  • 6.6. Market Attractiveness Analysis

7. Europe Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Technology Type
    • 7.2.3. By End User
  • 7.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 7.4.1. Wire Localization
    • 7.4.2. Radioguided Localization
    • 7.4.3. Magnetic Localization
    • 7.4.4. Ultrasound-guided Localization
    • 7.4.5. Stereotactic Localization
  • 7.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 7.5.1. Hospitals
    • 7.5.2. Diagnostic Imaging Centers
    • 7.5.3. Specialty Clinics
  • 7.6. Market Attractiveness Analysis

8. East Asia Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Technology Type
    • 8.2.3. By End User
  • 8.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 8.4.1. Wire Localization
    • 8.4.2. Radioguided Localization
    • 8.4.3. Magnetic Localization
    • 8.4.4. Ultrasound-guided Localization
    • 8.4.5. Stereotactic Localization
  • 8.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 8.5.1. Hospitals
    • 8.5.2. Diagnostic Imaging Centers
    • 8.5.3. Specialty Clinics
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Technology Type
    • 9.2.3. By End User
  • 9.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 9.4.1. Wire Localization
    • 9.4.2. Radioguided Localization
    • 9.4.3. Magnetic Localization
    • 9.4.4. Ultrasound-guided Localization
    • 9.4.5. Stereotactic Localization
  • 9.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 9.5.1. Hospitals
    • 9.5.2. Diagnostic Imaging Centers
    • 9.5.3. Specialty Clinics
  • 9.6. Market Attractiveness Analysis

10. Latin America Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Technology Type
    • 10.2.3. By End User
  • 10.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 10.4.1. Wire Localization
    • 10.4.2. Radioguided Localization
    • 10.4.3. Magnetic Localization
    • 10.4.4. Ultrasound-guided Localization
    • 10.4.5. Stereotactic Localization
  • 10.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 10.5.1. Hospitals
    • 10.5.2. Diagnostic Imaging Centers
    • 10.5.3. Specialty Clinics
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Technology Type
    • 11.2.3. By End User
  • 11.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 11.3.1. GCC
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 11.4.1. Wire Localization
    • 11.4.2. Radioguided Localization
    • 11.4.3. Magnetic Localization
    • 11.4.4. Ultrasound-guided Localization
    • 11.4.5. Stereotactic Localization
  • 11.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostic Imaging Centers
    • 11.5.3. Specialty Clinics
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
    • 12.2.3. Apparent Production Capacity
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Merit Medical Systems
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. BD
    • 12.3.3. ARGON MEDICAL
    • 12.3.4. Hologic, Inc.
    • 12.3.5. Endomagnetics Ltd.
    • 12.3.6. MatekMedikal
    • 12.3.7. Sirius Medical Systems B.V.
    • 12.3.8. Izi Medical Products, LLC
    • 12.3.9. Molli Surgical Inc
    • 12.3.10. Elucent Medical
    • 12.3.11. Intramedical Imaging
    • 12.3.12. Isoaid
    • 12.3.13. Vigeosrl
    • 12.3.14. Medax Medical Devices
    • 12.3.15. MDL SRL
    • 12.3.16. BPB Medica
    • 12.3.17. Sterylab S.R.L.
    • 12.3.18. Tsunami Medical Srl
    • 12.3.19. Laurane(R) Medical LLC
    • 12.3.20. Biomedical Srl

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations